WHO received the first report of an oseltamivir-resistant pandemic virus in July.

All of these viruses show the same H275Y mutation that confers resistance to the antiviral oseltamivir, but not to the antiviral zanamivir.

所有这些病毒都呈现出同样的H275Y变异，对奥司他韦抗病毒药物产生了耐药性，但却并不对扎那米韦抗病毒药物具有耐药性。

The control groups were treated with oral Oseltamivir Capsules, 75mg/ time, twice a day.

对照组均予口服磷酸奥司他韦胶囊，75mg／次，一天两次，观察其临床疗效。

Four were isolated from samples from patients receiving oseltamivir treatment.

4个耐药性病毒来自接受奥司他韦治疗的患者样本。

I believe the early distribution of stockpiles of oseltamivir to developing countries was useful.

我认为，早期向发展中国家分发储存的奥司他韦具有益处。

He was treated with the antiviral drug, oseltamivir.

他被给予抗病毒药奥司他韦进行治疗。

WHO has offered to send oseltamivir, an antiviral drug that can be used prophylactically, to reduce the risk of human infection and disease, as well as therapeutically.

世卫组织已提出发送奥司他韦（oseltamivir），一种抗病毒药物，既可用于预防以减少人类感染和疾病的危险，也可用于治疗。

Resistance to oseltamivir did not become widespread.

对奥司他韦的耐药性没有普遍发生。

The viruses, while resistant to oseltamivir, remain sensitive to zanamivir.

这些病毒对奥司他韦具有耐药性，但对扎那米韦仍是敏感的。

Many advanced countries stock up on oseltamivir and zanamivir, two varieties of the same class of drugs that stops the H5N1 virus from multiplying.

许多发达国家储备了药物奥司他韦（oseltamivir）和扎那米韦（Zanamivir）。它们是阻止H5N1病毒繁殖药物的两个品种。

All other viruses have been shown sensitive to both oseltamivir and zanamivir.

所有其它病毒显示对奥司他韦和扎那米韦都是敏感的。

In preparation for a bird flu pandemic and in the absence of a vaccine, countries are racing to stockpile the flu drug oseltamivir, which Roche produces under the trade name Tamiflu.

在为了禽流感瘟疫大爆发进行的准备中，各国还没有发现有效的疫苗。现在它们在互相比赛着来囤积奥司他韦（oseltamivir），这是瑞士罗氏公司的专利药，商品名达菲（Tamiflu）。

Both cases were admitted to Zagazig Fever Hospital where they received oseltamivir and are in a stable condition.

这两个病例均被Zagazig发热医院收治并使用奥司他韦进行治疗，目前病情稳定。

Advances in the research on new antiviral drug oseltamivir in treating influenza

抗病毒新药磷酸奥司他韦治疗流行性感冒的研究进展

Growing international experience in the treatment of pandemic H1N1 virus infections underscores the importance of early treatment with the antiviral drugs, oseltamivir or zanamivir.

在治疗H1N1大流行性流感病毒感染方面，越来越多的国际经验显示了使用奥司他韦和扎那米韦抗病毒药物进行早期治疗的重要性。

The clinical value of oseltamivir has been questioned.

奥司他韦的临床价值受到了质疑。

Six were associated with the use of oseltamivir treatment in patients with severe immunosuppression.

6个耐药性病毒与使用奥司他韦治疗免疫功能严重低下患者有关。

Oseltamivir Phosphate: A Front New Drug of Anti-A/ H1N1 Flu Virus Epidemiology and Analysis of Sensitivity for Antibiotics of Bacteremia in Intensive Care Unit

抗甲型H1N1流感病毒前沿新药&磷酸奥司他韦ICU菌血症流行病学及抗菌药物敏感性分析

In addition, community surveillance for oseltamivir-resistant pandemic H1N1 virus strains should be enhanced.

此外，应该加强对奥司他韦具有耐药性的H1N1大流行性流感病毒株的社区监督。

Does WHO still recommend oseltamivir use now that the pandemic is over?

大流行既然已经结束，世卫组织是否仍建议使用奥司他韦？

WHO spokesman Paul Garwood says U.N. agencies and the Haitian government will conduct a campaign next week to hundreds of thousands of children under age five against measles, tetanus and diphtheria.

WHOW发言人Paul Garwood表示，联合国机构和海地政府下周将为数千名5岁以下儿童接种麻疹，破伤风和白喉疫苗。